🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04507997
Recruiting Observational

Angelman Syndrome Natural History Study

NCT04507997 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2018-08-01
Last updated
2025-04-03

Condition(s) studied

Angelman Syndrome

Study summary

The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Molecular diagnosis of Angelman syndrome Exclusion Criteria: * Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment

Primary outcome measure(s)

Trial sites (11)

FacilityCityRegionStatus
Cedars-Sinai Guerin Children's Los Angeles California Not Yet Recruiting
Rady Children's Hospital, San Diego San Diego California Recruiting
Children's Hospital Colorado, Anschutz Medical Campus Aurora Colorado Recruiting
Emory University School of Medicine Atlanta Georgia Recruiting
Rush University Children's Hospital Chicago Illinois Recruiting
Boston Children's Hospital Boston Massachusetts Recruiting
The Carolina Institute for Developmental Disabilities Carrboro North Carolina Recruiting
Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville Tennessee Recruiting
Alberta Children's Hospital Calgary Alberta Recruiting
BC Children's Hospital Vancouver British Columbia Recruiting
Children's Hospital of Eastern Ontario Ottawa Ontario Recruiting

More Boston Children's Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04507997 on ClinicalTrials.gov ↗ ← All trials in Canada